Back to Search
Start Over
Neuraminidase of 2007–2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution
- Source :
- Antiviral Therapy, Antiviral Therapy, 2011, 16 (4), pp.597-603. ⟨10.3851/IMP1804⟩, Antiviral Therapy, International Medical Press, 2011, 16 (4), pp.597-603. ⟨10.3851/IMP1804⟩
- Publication Year :
- 2011
- Publisher :
- HAL CCSD, 2011.
-
Abstract
- Background During the 2007–2008 season, A(H1N1) viruses naturally resistant to oseltamivir due to an H275Y substitution in the neuraminidase emerged and spread in the human population. The neuraminidase of 2007–2008 A(H1N1) viruses has an increased affinity for sialic acids as compared with the N1 of previously circulating viruses. Methods Using site-directed mutagenesis analysis and an enzymatic assay on cells transiently expressing the viral neuraminidase, the amino acid changes that could account for the particular enzymatic properties of the neuraminidase of 2007–2008 A(H1N1) viruses were explored. The affinity for the substrate ( K m) and the inhibition constants for inhibitors ( K i) were determined for wild-type and mutated neuraminidases. Reverse genetics was used to produce 6:2 reassortant viruses expressing haemagglutinin and neuraminidase derived from A(H1N1) viruses of the 2007–2008 season or from a previously circulating H1N1 virus, in an A/WSN/33 background. Results The D344N substitution characteristic of the N1 of 2007–2008 A(H1N1) viruses was identified as a major determinant of its increased affinity for sialic acids. According to the viral plaque phenotype of the 6:2 reas-sortant viruses, the H275Y mutation was deleterious when the surface glycoproteins were derived from the H1N1 virus isolated in 2004, but not when they were derived from A(H1N1) viruses of the 2007–2008 season. Conclusions The D344N substitution, by modifying the enzymatic property of the N1, may have favoured the emergence and spread of viruses naturally resistant to oseltamivir.
- Subjects :
- Models, Molecular
viruses
[SDV]Life Sciences [q-bio]
medicine.disease_cause
Virus Replication
chemistry.chemical_compound
Influenza A Virus, H1N1 Subtype
Influenza A virus
Pharmacology (medical)
chemistry.chemical_classification
0303 health sciences
education.field_of_study
MESH: Drug Resistance, Viral
biology
MESH: Influenza, Human
virus diseases
MESH: Neuraminidase
MESH: Amino Acid Substitution
3. Good health
MESH: Mutagenesis, Site-Directed
Infectious Diseases
MESH: Models, Molecular
MESH: Antiviral Agents
Oseltamivir
Orthomyxoviridae
Population
Neuraminidase
Antiviral Agents
MESH: Sialic Acids
Virus
Microbiology
Cell Line
MESH: Influenza A Virus, H1N1 Subtype
03 medical and health sciences
MESH: Oseltamivir
Drug Resistance, Viral
Influenza, Human
medicine
Humans
education
030304 developmental biology
Pharmacology
MESH: Humans
030306 microbiology
MESH: Virus Replication
biology.organism_classification
Virology
Sialic acid
respiratory tract diseases
MESH: Cell Line
Enzyme
chemistry
Amino Acid Substitution
biology.protein
Mutagenesis, Site-Directed
Sialic Acids
Subjects
Details
- Language :
- English
- ISSN :
- 13596535
- Database :
- OpenAIRE
- Journal :
- Antiviral Therapy, Antiviral Therapy, 2011, 16 (4), pp.597-603. ⟨10.3851/IMP1804⟩, Antiviral Therapy, International Medical Press, 2011, 16 (4), pp.597-603. ⟨10.3851/IMP1804⟩
- Accession number :
- edsair.doi.dedup.....64a043422a121744e8c0f07291a07cae
- Full Text :
- https://doi.org/10.3851/IMP1804⟩